| COMMON NAME |
AIN457 |
|---|---|
| SYNONYMS |
CTLA-8;TLA8;L-17;L-17A;L17 |
| APPLICATIONS |
Flow Cyt |
| RECOMMENDED DILUTIONS |
Flow Cyt 1:100 |
| FORMULATION & RECONSTITUTION |
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
| HOST SPECIES |
Homo sapiens |
| IGG TYPE |
IgG1 |
| REACTIVITY |
Human |
| TARGET | |
| UNIPROT ID |
Q16552 |
| DESCRIPTION |
Anti-IL17A(secukinumab biosimilar) mAb |
| DELIVERY |
In Stock |
| STORAGE & SHIPPING |
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |
| BACKGROUND |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| USAGE |
Research use only |
Dima Biotech
SKU(재고 관리 코드):BME100137
Anti-IL17A(secukinumab biosimilar) mAb
Anti-IL17A(secukinumab biosimilar) mAb
PRODUCT DATA
IMAGES
Figure 1. Flow cytometry analysis under cell membrane permeable condition with 1 μg/mL Anti-IL17A (secukinumab biosimilar) mAb (BME100137) on Expi293 cells transfected with Human IL17A protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
